New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 15, 2014
10:01 EDTMTGE, VOD, VOXX, URBN, TOT, STO, SWN, O, PHMD, LFL, ITC, HII, CXP, BMY, BEAV, AAUKY, WACOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: American Capital Mortgage (MTGE) downgraded to Market Perform at JMP Securities... Anglo American (AAUKY) downgraded to Neutral from Outperform at Credit Suisse... BE Aerospace (BEAV) downgraded to Neutral from Buy at UBS... Bristol-Myers (BMY) downgraded at BMO Capital... Columbia Property Trust (CXP) downgraded to Equal Weight from Overweight at Morgan Stanley... Huntington Ingalls (HII) downgraded at BofA/Merrill... ITC Holdings (ITC) downgraded to Neutral from Overweight at JPMorgan... LATAM Airlines (LFL) downgraded to Market Perform from Outperform at Raymond James... PhotoMedex (PHMD) downgraded to Hold from Buy at Ascendiant... Realty Income (O) downgraded to Neutral from Buy at Ladenburg... Southwestern Energy (SWN) downgraded to Neutral from Conviction Buy at Goldman... Statoil (STO) downgraded to Sector Perform from Top Pick at RBC Capital... Total (TOT) downgraded to Sector Perform from Outperform at RBC Capital... Urban Outfitters (URBN) downgraded to Market Perform from Outperform at FBR Capital... VOXX International (VOXX) downgraded to Neutral from Buy at B. Riley... Vodafone (VOD) downgraded to Neutral from Buy at Goldman... Walter Investment (WAC) downgraded to Sell from Neutral at Compass Point.
News For MTGE;AAUKY;BEAV;BMY;CXP;HII;ITC;LFL;PHMD;O;SWN;STO;TOT;URBN;VOXX;VOD;WAC From The Last 14 Days
Check below for free stories on MTGE;AAUKY;BEAV;BMY;CXP;HII;ITC;LFL;PHMD;O;SWN;STO;TOT;URBN;VOXX;VOD;WAC the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
August 27, 2014
07:33 EDTCXPW.P. Carey acquires $47M office facility from Columbia Property Trust
Subscribe for More Information
06:42 EDTBMYBristol-Myers initiated with a Hold at Deutsche Bank
Target $52.
06:29 EDTTOTShell consortium nears deal to sell Nigeria oilfields for $5B, FT reports
Subscribe for More Information
06:25 EDTSTOStatoil says it has over 100 projects in planning or execution, WSJ reports
Statoil says it has over 100 projects in planning or in progress, and is planning to maintain its current oil and gas production in coming years with the record activity, the Wall Street Journal reports. Reference Link
05:44 EDTBMYBristol-Myers Daklinza approved by EC
Bristol-Myers announced that the European Commission, or EC, has approved Daklinza for use in combination with other medicinal products across genotypes 1, 2, 3 and 4 for the treatment of chronic hepatitis C virus, or HCV, infection in adults. Daklinza, when used in combination with sofosbuvir, is an all-oral, interferon-free regimen that provided cure rates of up to 100% in clinical trials, including patients with advanced liver disease, genotype 3 and those who have previously failed treatment with protease inhibitors. Daklinza is the first NS5A complex inhibitor approved in the European Union and will be available for use in combination with other medicinal products, providing a shorter treatment duration compared to 48 weeks of treatment with interferon- and ribavirin-based regimens. The approval allows for the marketing of Daklinza in all 28 Member States of the EU. The marketing authorization for Daklinza follows an accelerated assessment by the Committee for Medicinal Products for Human Use, a designation that is granted to new medicines of major public health interest.
August 25, 2014
11:11 EDTURBNOptions with decreasing implied volatility
Options with decreasing implied volatility: AMPE FOLD ITMN AEO DKS WUBA URBN SPLS YOKU GME
06:24 EDTSTOStatoil sees some delays in Russian energy projects from sanctions, WSJ reports
Subscribe for More Information
August 22, 2014
12:39 EDTBMYThese five companies will benefit from increased ALS awareness, MarketWatch says
A recent surge in funding for Lou Gehrig's disease, or ALS, caused by the Ice Bucket challenge that is widespread on social media outlets, will benefit five pharmaceutical companies that are involved in the development of a cure for ALS, according to MarketWatch. The companies that are or have been involved in developing a treatment for ALS include Biogen Idec (BIIB), Avanir Pharmaceuticals (AVNR), Isis Pharmaceuticals (ISIS), Sanofi (SNY), and Bristol-Myers Squibb (BMY), MarketWatch added. Reference Link
10:15 EDTVODVodafone rallies amid reports of AT&T takeover bid, FT says
Subscribe for More Information
07:11 EDTVODAT&T may mount bid GBP3 per share bid for Vodafone, Daily Mail reports
AT&T (T) is working on a cash bid worth over GBP3 per share for Vodafone (VOD), according to the Daily Mail. The publication says China Mobile (CHL) may be interested in taking a stake in Vodafone of up to 20%. Reference Link
August 21, 2014
13:32 EDTBMYBristol-Myers, Pfizer announce approval of Eliquis for treatment of DVT, PE
Subscribe for More Information
August 20, 2014
08:03 EDTBMYBristol-Myers Pfizer to present new Eliquis data
Subscribe for More Information
08:02 EDTBMYBristol-Myers, Celgene enter collaboration agreement for OPDIVO, ABRAXANE
Subscribe for More Information
05:20 EDTVODEricsson to upgrade Vodafone Australia network
Subscribe for More Information
August 19, 2014
15:54 EDTSWNEnerCom to hold a conference
Subscribe for More Information
11:53 EDTURBNAeropostale soars as Geiger returns as CEO
Subscribe for More Information
10:13 EDTURBNOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:01 EDTURBNUrban Outfitters shares should be bought on weakness, says Stifel
Subscribe for More Information
07:14 EDTURBNUrban Outfitters Urban brand turnaround on track, says RBC Capital
Subscribe for More Information
05:24 EDTURBNUrban Outfitters upgraded to Outperform from Neutral at RW Baird
RW Baird upgraded Urban Outfitters to Outperform citing a more favorable risk/reward following the company's Q2 results. Baird highlights merchandise improvements at the namesake brand and momentum at Anthropologie and Free People. The firm raised its price target for shares to $44 from $40.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use